ES2111579T3 - Preparaciones de factor viii estabilizadas. - Google Patents

Preparaciones de factor viii estabilizadas.

Info

Publication number
ES2111579T3
ES2111579T3 ES92104944T ES92104944T ES2111579T3 ES 2111579 T3 ES2111579 T3 ES 2111579T3 ES 92104944 T ES92104944 T ES 92104944T ES 92104944 T ES92104944 T ES 92104944T ES 2111579 T3 ES2111579 T3 ES 2111579T3
Authority
ES
Spain
Prior art keywords
factor viii
viii preparations
stabilized factor
stabilized
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92104944T
Other languages
English (en)
Other versions
ES2111579T4 (es
Inventor
Wilfried Freudenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centeon Pharma GmbH
Original Assignee
Centeon Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6429102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2111579(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centeon Pharma GmbH filed Critical Centeon Pharma GmbH
Publication of ES2111579T3 publication Critical patent/ES2111579T3/es
Application granted granted Critical
Publication of ES2111579T4 publication Critical patent/ES2111579T4/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PREPARACIONES DE FACTOR VIII ESTABILIZADAS. LA INVENCION TRATA DE SOLUCIONES ESTABILIZADAS CON ACTIVIDAD DE COAGULACION F VIII, UN PROCEDIMIENTO PARA SU PRODUCCION Y TAMBIEN DE SU UTILIZACION.
ES92104944T 1991-04-09 1992-03-21 Preparaciones de factor viii estabilizadas. Expired - Lifetime ES2111579T4 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4111393A DE4111393A1 (de) 1991-04-09 1991-04-09 Stabilisierte faktor viii-praeparationen
DE4111393 1991-04-09

Publications (2)

Publication Number Publication Date
ES2111579T3 true ES2111579T3 (es) 1998-03-16
ES2111579T4 ES2111579T4 (es) 2011-12-29

Family

ID=6429102

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92104944T Expired - Lifetime ES2111579T4 (es) 1991-04-09 1992-03-21 Preparaciones de factor viii estabilizadas.

Country Status (12)

Country Link
US (1) US5565427C1 (es)
EP (1) EP0508194B1 (es)
JP (2) JP3777467B2 (es)
KR (1) KR100231398B1 (es)
AT (1) ATE160942T1 (es)
AU (1) AU651188B2 (es)
CA (1) CA2065553C (es)
DE (2) DE4111393A1 (es)
DK (1) DK0508194T3 (es)
ES (1) ES2111579T4 (es)
GR (1) GR3025873T3 (es)
IE (1) IE921124A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2229931A1 (es) * 2003-10-03 2005-04-16 Probitas Pharma, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100303872B1 (ko) * 1992-10-02 2001-11-22 크리스터 발스트룀, 프레드릭 베르그, 하랄트 알름 응고인자ⅷ제형을포함하는조성물,이것의제조방법및안정화제로서의계면활성제의사용방법
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
SE504074C2 (sv) † 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
US6372716B1 (en) 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US7244824B2 (en) * 1995-01-19 2007-07-17 Quadrant Drug Delivery Limited Dried blood factor composition comprising trehalose
GB9501040D0 (en) * 1995-01-19 1995-03-08 Quadrant Holdings Cambridge Dried composition
US7253262B2 (en) * 1995-01-19 2007-08-07 Quandrant Drug Delivery Limited Dried blood factor composition comprising trehalose
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
EP1154796B1 (en) * 1999-02-22 2007-06-20 University of Connecticut Novel albumin-free factor viii formulations
WO2001024814A1 (en) 1999-10-04 2001-04-12 Chiron Corporation Stabilized liquid polypeptide-containing pharmaceutical compositions
GB0207092D0 (en) 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII
CA2512681A1 (en) 2003-01-08 2004-07-29 Chiron Corporation Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
ES2911435T3 (es) 2003-02-26 2022-05-19 Nektar Therapeutics Conjugados de polímero-resto de Factor VIII
DE10333317A1 (de) † 2003-07-22 2005-02-17 Biotecon Therapeutics Gmbh Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
EP1750733B1 (en) 2004-05-03 2013-12-11 Emory University METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII
DK1835938T3 (da) 2004-12-27 2013-11-04 Baxter Int Polymer-von Willebrand-faktor-konjugater
EP2264162A1 (en) * 2005-07-02 2010-12-22 Arecor Limited Stable aqueous systems comprising proteins
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
JP2009532351A (ja) * 2006-03-31 2009-09-10 バクスター・インターナショナル・インコーポレイテッド ペグ化第ｖｉｉｉ因子
PL2126106T3 (pl) * 2007-02-23 2018-03-30 Sk Chemicals Co., Ltd. Sposób produkcji i oczyszczania czynnika VIII i jego pochodnych
CN103990116A (zh) 2007-04-26 2014-08-20 拜尔健康护理有限责任公司 稳定用于冷冻储藏的重组蛋白液体溶液的方法
AU2009284113B2 (en) 2008-08-21 2015-05-14 Octapharma Ag Recombinantly produced human factor VIII and IX
WO2010026186A1 (en) * 2008-09-03 2010-03-11 Octapharma Ag New protecting compositions for recombinantly produced factor viii
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
US10172949B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
TWI626057B (zh) 2009-06-09 2018-06-11 普龍製藥有限責任公司 血紅素組成物
US10172950B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
GB0915480D0 (en) 2009-09-04 2009-10-07 Arecor Ltd Stable formulation of factor viii
CN103282042B (zh) * 2010-09-17 2014-12-10 巴克斯特国际公司 通过具有组氨酸的水性制剂在弱酸性至中性pH稳定的免疫球蛋白
DK2635297T3 (da) 2010-11-05 2019-05-06 Baxalta GmbH En ny variant af antihæmofil faktor viii, der har en øget specifik aktivitet
CN103562410B (zh) 2011-04-08 2016-09-28 伯乐实验室公司 具有降低的非特异性活性的sso7-聚合酶缀合物
SG193990A1 (en) 2011-04-08 2013-11-29 Bio Rad Laboratories Pcr reaction mixtures with decreased non-specific activity
CA2850579A1 (en) 2011-10-18 2013-04-25 Carsten Horn Method for improving the stability of purified factor viii after reconstitution
CN102580062B (zh) * 2012-03-09 2017-03-08 中国医学科学院输血研究所 人凝血因子VIII与vWF复合物或人凝血因子VIII制剂的干热处理稳定剂
JP2014138614A (ja) * 2014-04-09 2014-07-31 Sk Chemicals Co Ltd 第ｖｉｉｉ因子とその誘導体の製造及び精製方法
PL3177317T3 (pl) 2014-08-04 2020-07-27 Csl Limited Formulacja czynnika viii
CN114072420B (zh) 2019-07-04 2024-06-11 康诺贝林伦瑙有限公司 用于增加凝血因子viii的体外稳定性的截短的血管性血友病因子(vwf)
US20220380439A1 (en) 2020-11-09 2022-12-01 Takeda Pharmaceutical Company Limited Purification of fviii from plasma using silicon oxide adsorption

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB941019A (en) * 1961-04-27 1963-11-06 Crookes Lab Ltd Improvements in and relating to the stability of anti-haemophilic globulin (factor viii)
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
EP0148843B2 (en) * 1983-03-21 1994-05-04 Novo Nordisk A/S A concentrate of the antihemophilic factor viii and a process for producing it
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
CA1329760C (en) * 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
JP4021982B2 (ja) * 1998-03-03 2007-12-12 信越化学工業株式会社 ハイブリッド型ウイグラ

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2229931A1 (es) * 2003-10-03 2005-04-16 Probitas Pharma, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.

Also Published As

Publication number Publication date
EP0508194B1 (de) 1997-12-10
JP2002097199A (ja) 2002-04-02
CA2065553C (en) 2003-06-10
US5565427C1 (en) 2002-07-23
JP3809501B2 (ja) 2006-08-16
KR920019371A (ko) 1992-11-19
JPH0597702A (ja) 1993-04-20
JP3777467B2 (ja) 2006-05-24
AU1470292A (en) 1992-10-15
IE921124A1 (en) 1992-10-21
EP0508194A1 (de) 1992-10-14
ATE160942T1 (de) 1997-12-15
AU651188B2 (en) 1994-07-14
KR100231398B1 (ko) 1999-11-15
CA2065553A1 (en) 1992-10-10
DE59209051D1 (de) 1998-01-22
DK0508194T3 (da) 1998-08-24
GR3025873T3 (en) 1998-04-30
ES2111579T4 (es) 2011-12-29
DE4111393A1 (de) 1992-10-15
US5565427A (en) 1996-10-15

Similar Documents

Publication Publication Date Title
US5565427C1 (en) Stabilized factor viii preparations
DE69002795D1 (de) Stabilisierte, den epidermalen wachstumsfaktor enthaltende mittel.
DE69130020D1 (de) Stabilisierte, retinoide enthaltende hautpflegepräparate
DE69202739D1 (de) Gemischtes Alkylmethylsiloxane zur Hautpflege.
NO924895D0 (no) Blekekatalysator, samt fremgangsmaate for bleking
ES2136105T3 (es) Preparacion farmaceutica y/o cosmetica.
DE68906293D1 (de) Zufuhr von kohlendioxid.
FI914226A0 (fi) Glykosylerade insulin.
DE3870959D1 (de) 2-difluormethoxy-1,1,1,2-tetrafluoraethan als anaesthetikum.
IT8834049V0 (it) Irroratore oscillante perfezionato.
DE68900210D1 (de) Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen.
DE68913090D1 (de) Modifizierter menschlicher PSTI.
NO893695D0 (no) Stabiliserte tiokarbonatopploesninger.
IT8921236A0 (it) Procedimento per produrre pezzi stampati e dispositivo per l'esecuzione del procedimento.
IT8919814A0 (it) Dispositivo di bloccaggio e regolazione, particolarmente per compassi da disegnatore.
ES1011526Y (es) Invernadero perfeccionado.
IT208775Z2 (it) Siringa per l'anestesia intraligamentosa.
ES1006246Y (es) Tijera perfeccionada.
ITTO930116A0 (it) Procedimento per preparare uan soluzione contentente semitrichinoyl, con proprieta' terapeutiche.
ES1007581Y (es) Biberon desechable.
IT9003745A0 (it) Ago a farfalla di sicurezza per uso medicale.
ES1006662Y (es) Mesa perfeccionada.
ATE105196T1 (de) Nadelloses einweg-injektionssystem.
ES1021060Y (es) Mesa perfeccionada.
ES1021012Y (es) Mesa perfeccionada.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 508194

Country of ref document: ES